CD109, a master regulator of inflammatory responses

Inflammation is a complex response to harmful stimuli, crucial for immunity, and linked to chronic diseases and cancer, with TGF-β and NF-κB pathways as key regulators. CD109 is a glycosylphosphatidylinositol (GPI)-anchored protein, that our group has originally identified as a TGF-β co-receptor and...

Full description

Saved in:
Bibliographic Details
Main Authors: Adel Batal, Setareh Garousi, Kenneth W. Finnson, Anie Philip
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1505008/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825206692942446592
author Adel Batal
Adel Batal
Setareh Garousi
Setareh Garousi
Kenneth W. Finnson
Kenneth W. Finnson
Anie Philip
Anie Philip
author_facet Adel Batal
Adel Batal
Setareh Garousi
Setareh Garousi
Kenneth W. Finnson
Kenneth W. Finnson
Anie Philip
Anie Philip
author_sort Adel Batal
collection DOAJ
description Inflammation is a complex response to harmful stimuli, crucial for immunity, and linked to chronic diseases and cancer, with TGF-β and NF-κB pathways as key regulators. CD109 is a glycosylphosphatidylinositol (GPI)-anchored protein, that our group has originally identified as a TGF-β co-receptor and inhibitor of TGF-β signaling. CD109 modulates TGF-β and NF-κB pathways, to influence immune responses and inflammation. CD109’s multifaceted role in inflammation spans various tissue types, including the skin, lung, bone and bone-related tissues, and various types of cancers. CD109 exerts its effects by modulating processes such as cytokine secretion, immune cell recruitment, macrophage polarization, T helper cell function and cancer cell phenotype and function. Here, we review CD109’s regulatory functions in inflammatory responses in these various tissues and cell types. Exploration of CD109’s mechanisms of action will enhance our understanding of its contributions to disease pathology and its potential for therapeutic applications.
format Article
id doaj-art-19fdda76ad3941d9b4a920fb6ea8a019
institution Kabale University
issn 1664-3224
language English
publishDate 2025-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-19fdda76ad3941d9b4a920fb6ea8a0192025-02-07T06:49:49ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-02-011510.3389/fimmu.2024.15050081505008CD109, a master regulator of inflammatory responsesAdel Batal0Adel Batal1Setareh Garousi2Setareh Garousi3Kenneth W. Finnson4Kenneth W. Finnson5Anie Philip6Anie Philip7Division of Plastic Surgery, Department of Surgery, McGill University, Montreal, QC, CanadaSurgical and Interventional Sciences Program, The Research Institute of the McGill University Health Centre, Montreal, QC, CanadaDivision of Plastic Surgery, Department of Surgery, McGill University, Montreal, QC, CanadaSurgical and Interventional Sciences Program, The Research Institute of the McGill University Health Centre, Montreal, QC, CanadaDivision of Plastic Surgery, Department of Surgery, McGill University, Montreal, QC, CanadaSurgical and Interventional Sciences Program, The Research Institute of the McGill University Health Centre, Montreal, QC, CanadaDivision of Plastic Surgery, Department of Surgery, McGill University, Montreal, QC, CanadaSurgical and Interventional Sciences Program, The Research Institute of the McGill University Health Centre, Montreal, QC, CanadaInflammation is a complex response to harmful stimuli, crucial for immunity, and linked to chronic diseases and cancer, with TGF-β and NF-κB pathways as key regulators. CD109 is a glycosylphosphatidylinositol (GPI)-anchored protein, that our group has originally identified as a TGF-β co-receptor and inhibitor of TGF-β signaling. CD109 modulates TGF-β and NF-κB pathways, to influence immune responses and inflammation. CD109’s multifaceted role in inflammation spans various tissue types, including the skin, lung, bone and bone-related tissues, and various types of cancers. CD109 exerts its effects by modulating processes such as cytokine secretion, immune cell recruitment, macrophage polarization, T helper cell function and cancer cell phenotype and function. Here, we review CD109’s regulatory functions in inflammatory responses in these various tissues and cell types. Exploration of CD109’s mechanisms of action will enhance our understanding of its contributions to disease pathology and its potential for therapeutic applications.https://www.frontiersin.org/articles/10.3389/fimmu.2024.1505008/fullCD109inflammatory responseTGF-β signalingNF-κB signalingpathway crosstalk
spellingShingle Adel Batal
Adel Batal
Setareh Garousi
Setareh Garousi
Kenneth W. Finnson
Kenneth W. Finnson
Anie Philip
Anie Philip
CD109, a master regulator of inflammatory responses
Frontiers in Immunology
CD109
inflammatory response
TGF-β signaling
NF-κB signaling
pathway crosstalk
title CD109, a master regulator of inflammatory responses
title_full CD109, a master regulator of inflammatory responses
title_fullStr CD109, a master regulator of inflammatory responses
title_full_unstemmed CD109, a master regulator of inflammatory responses
title_short CD109, a master regulator of inflammatory responses
title_sort cd109 a master regulator of inflammatory responses
topic CD109
inflammatory response
TGF-β signaling
NF-κB signaling
pathway crosstalk
url https://www.frontiersin.org/articles/10.3389/fimmu.2024.1505008/full
work_keys_str_mv AT adelbatal cd109amasterregulatorofinflammatoryresponses
AT adelbatal cd109amasterregulatorofinflammatoryresponses
AT setarehgarousi cd109amasterregulatorofinflammatoryresponses
AT setarehgarousi cd109amasterregulatorofinflammatoryresponses
AT kennethwfinnson cd109amasterregulatorofinflammatoryresponses
AT kennethwfinnson cd109amasterregulatorofinflammatoryresponses
AT aniephilip cd109amasterregulatorofinflammatoryresponses
AT aniephilip cd109amasterregulatorofinflammatoryresponses